Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
40.86
-0.38 (-0.92%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,816,111
Open
41.20
Bid (Size)
40.42 (1)
Ask (Size)
41.30 (1)
Prev. Close
41.24
Today's Range
40.63 - 41.24
52wk Range
33.33 - 43.84
Shares Outstanding
5,385,189,617
Dividend Yield
3.53%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
April 19, 2024
Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages since 2020. Learn about challenges in medicine supplies, regulatory...
Via
Benzinga
Topics
Brexit
Exposures
Brexit
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
April 18, 2024
Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential...
Via
Benzinga
Performance
YTD
+8.93%
+8.93%
1 Month
-4.60%
-4.60%
3 Month
+4.69%
+4.69%
6 Month
+13.34%
+13.34%
1 Year
+10.70%
+10.70%
More News
Read More
GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years
April 17, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
April 11, 2024
Via
Benzinga
Down 75%. Is Agenus Stock a Buy on the Dip?
April 08, 2024
Via
The Motley Fool
Peering Into GSK's Recent Short Interest
March 26, 2024
Via
Benzinga
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
Via
Benzinga
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
April 04, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
April 03, 2024
Via
MarketBeat
Exposures
Product Safety
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
April 03, 2024
Via
The Motley Fool
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
March 24, 2024
Via
The Motley Fool
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
March 21, 2024
Via
Benzinga
GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer
March 18, 2024
Via
Benzinga
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
March 18, 2024
Via
Benzinga
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
March 16, 2024
From
GSK plc
Via
Business Wire
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
Via
InvestorPlace
Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead
March 11, 2024
Via
InvestorPlace
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
March 11, 2024
Via
Benzinga
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Via
InvestorPlace
GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study
March 07, 2024
Via
Benzinga
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 07, 2024
From
GSK plc
Via
Business Wire
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
March 06, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.